Management ChangeMay 18, 2026, 04:27 PM
Innoviva Board Sees Two Departures, Elects Josephine Linden
AI Summary
Innoviva, Inc. announced the resignations of Derek Small and Mark DiPaolo from its Board of Directors on May 12, 2026. Their departure was to concentrate on Syndeio BioSciences Inc., a company Innoviva has invested in. The company subsequently elected Josephine Linden to the Board on May 18, 2026. Mrs. Linden, a seasoned investment professional and former Goldman Sachs Partner, will serve as an independent director and is expected to join the Audit Committee. Her compensation includes RSU awards totaling $331,250 and options for 9,166 shares.
Key Highlights
- Derek Small and Mark DiPaolo resigned from Innoviva's Board on May 12, 2026.
- Resignations were to focus on Syndeio BioSciences Inc., where Small is CEO.
- Josephine Linden was elected to the Board of Directors on May 18, 2026.
- Linden is founder of Linden Global Strategies LLC and former Goldman Sachs Partner.
- She is expected to serve on the Board's Audit Committee.
- Linden will receive a $125,000 Initial RSU award and a $206,250 Prorated Annual RSU award.
- She will also receive an award of options to purchase 9,166 shares of common stock.
Price Impact
More from INVA